<?xml version="1.0" encoding="UTF-8"?>
<ref id="B93-nanomaterials-10-01072">
 <label>93.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tao</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Hurst</surname>
    <given-names>B.L.</given-names>
   </name>
   <name>
    <surname>Shakya</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Uddin</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Ingrole</surname>
    <given-names>R.S.J.</given-names>
   </name>
   <name>
    <surname>Hernandez-Sanabria</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Arya</surname>
    <given-names>R.P.</given-names>
   </name>
   <name>
    <surname>Bimler</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Paust</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tarbet</surname>
    <given-names>E.B.</given-names>
   </name>
  </person-group>
  <article-title>Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>141</volume>
  <fpage>62</fpage>
  <lpage>72</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.01.021</pub-id>
  <pub-id pub-id-type="pmid">28161578</pub-id>
 </element-citation>
</ref>
